Director Jain Mudit K. of CVRx, Inc. (NASDAQ: CVRX) bought 46,800 shares of the company's common stock on February 20, 2026, in a transaction that totaled $297,591. The shares were purchased at prices ranging between $5.85 and $6.39, and the stock was trading at $6.11 at the time of this report following a 23% rise over the prior week.
After completing the purchase, Jain holds 5,650 shares directly. In addition, he has an indirect stake of 980,183 shares through Treo Ventures I, L.P., where he is listed as the General Partner. The disclosure of both direct and indirect holdings provides a current snapshot of the director's ownership profile following the recent transaction.
CVRx's latest quarterly results for the fourth quarter of 2025 were mixed. The company reported earnings per share of -$0.46, missing the consensus expectation of -$0.44. Revenue, however, came in at $16.0 million, exceeding the forecasted $15.72 million and representing a 4% increase year over year. Management's previously announced revenue guidance range of $15.9 million to $16.1 million was aligned with the reported figure.
Market analysts reacted to the quarter with adjustments to their outlooks. Canaccord Genuity kept a Buy rating on CVRx but lowered its price target from $11 to $10, citing a decline in the sector multiple as the reason for the reduced target.
Separately, InvestingPro analysis referenced in company reporting indicates that CVRX appears undervalued at current levels and points readers to additional paid resources for more in-depth commentary and research tools. The platform notes the availability of supplemental ProTips and a detailed Pro Research Report for investors seeking further analysis.
The combination of an insider purchase, a short-term stock price surge, and a quarter that beat on revenue while missing on EPS are the principal developments captured in the company's recent disclosures and analyst commentary. The record of direct and indirect holdings, the precise transaction pricing, and the quarter-end financials are drawn from the company and market reports filed for the relevant period.
Note: This article reports the disclosed transaction details, the company-reported quarterly results, and the cited analyst rating without offering investment recommendations.